Regenerative Medical Technology Group targets authorized common stock increase to 400 million shares

Reuters2026/08/28 17:44

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Board action on Aug. 17, 2026 set a plan to expand authorized common stock to 400,000,000 shares from 100,000,000.
Written consent from holders of 1,050,000 Series AA Preferred shares delivered 67% of voting power to authorize the amendment.
Increase targets share availability for conversions and exercises tied to about 184,156,824 common shares from outstanding securities and warrants.
Amendment expected to take effect on or after Sept. 7, 2026, subject to Nevada filing and the 20-day notice period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-094923), on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regenerative Medical Technology Group targets authorized common stock increase to 400 million shares

You may also like

Crypto prices